Download - Pemicu 4 - Elvina 2

8/19/2019 Pemicu 4 - Elvina 2

1/51

PEMICU IV

ELVINA ELIZABETH LIUS, TAN

405100277


2/51

Abstrak

1. Masala !

t"#$$"#%a BBL& '" P(sk)s*as +)a*ata#+(*ba#$a#

Alasa# -)*"l"a# ar"ab)l -)#%)bab !a#$ka BBL& sa#$at t"#$$" l)b" 'ar" '(a -)rt"$a'ar" k)la"ra# ba%" %a#$ k(ra#$ l)b" *)#a-a"200 k)la"ra#

T(/(a# !

*)#ar" (b(#$a# a#tara +as(s BBL& ')#$a#-ara "b( a*"l %a#$ ka'ar Hb #%a 11 *$ 'L.


3/51

2. M)t'l$"

3)sa"# ! Cas) #trl st('%,Lkas" akt( ! P(sk)s*as+)a*ata# +(*ba#$a#

6(*la sa*-)l ! 50 ba%" 55 ba%" T)k#"k -)#$a*b"la# sa*-)l ! arara#'*

Cara -)#$(*-(la# 'ata !Alat (k(r !

P)#$laa# 'ata !


4/51

. Has"l -)#)l"t"a# !


5/51

4. Sara#

5. +ata 8 kata k(#"


6/51

BAB I. PEN3AHULUAN

1. Latar B)laka#$ ! – T"#$$"#%a BBL& '" P(sk)s*as +)a*ata#

+(*ba#$a# s)la*a ta(# 2010

– Ba#%ak#%a "b( a*"l %a#$ ka'ar Hb #%a *$ 'L

2. P)r(*(sa# Masala

– 3" P(sk)s*as +)a*ata# +(*ba#$a# s)la*ata(# 2010 '"'a-at" l)b" 'ar" '(a -)rt"$a'ar" 200 k)la"ra# ba%" *)#$ala*" BBL&

9a#$ka BBL& t"#$$":


7/51

.T(/(a#

• T(/(a# (*(* !M)#(r(#ka# a#$ka BBL& '" P(sk)s*as

+)a*ata# +(*ba#$a#.

•Tujuan khusus : – Mengetahui mengapa ibu hamil dengan kadar

Hb rendah berpengaruh pada BBLR

– Mengetahui penyebab ibu hamil dengan

kadar Hb rendah tapi berat badan bayi cukup.


8/51

P)rta#%aa# Masala

1. B)ra-a ba#%ak BBL& -a'a "b( a*"l%a#$ *)*-(#%a" ka'ar Hb 11 *$'l 'a# /($a -a'a "b( a*"l %a#$ ka'ar

Hb #%a #r*al;2. 3ar" a#tara Ib( a*"l %a#$ ka'ar

Hb11 *$'l, b)ra-a %$ *)#$ala*"

BBL&;. A'aka (b(#$a# a#tara BBL&

')#$a# ka'ar Hb;


9/51

BAB II. TIN6AUAN PUSTA+A

BBL&

Tra(*a


10/51

• ANEMIA

A#)*"a a'ala t(r(##%a ka'ar s)l'ara *)ra ata( )*$lb"# 'ala*'ara.

A#)*"a b"asa#%a s('a 'a-at'"')t)ks" ')#$a# -)*)r"ksaa# 'aral)#$ka- '" labratr"(*.


11/51

• P)*)r"ksaa# 'ara l)#$ka- a'ala-)*)r"ksaa# %a#$ '"lak(ka# -a'a 'ara*a#(s"a ')#$a# *)#$"t(#$ s)l(r(

k*-#)# -)*b)#t(k 'ara. Saat "#"-)*)r"ksaa# 'ara l)#$ka- '"lak(ka#')#$a# *)#$$(#aka# *)s"# k(s(s.+*-#)# -)*b)#t(k 'ara a#tara la"# !

• S)l 'ara *)ra 9&BC:.• H)*atkr"t.• H)*$lb"#.• S)l 'ara -(t" 9BC:.

• +*-#)# s)l 'ara -(t".• Tr*bs"tPlat)l)t.• Ha#%a t"$a t)ratas 'ar" k))#a* k*-#)#

'ara "#" %a#$ b)r-)ra#a# 'ala*

*)#')t)ks" t)r/a'"#%a a#)*"a.


12/51

• S)l 'ara *)ra 9&BC: *)r(-aka#k*-#)# 'ara %a#$ t)rba#%ak 'ala*sat( *"l"l"t)r 'ara. S)t"a- ra#$ *)*"l"k"

/(taa# baka# *"l"ara# s)l 'ara *)ra'ala* t(b(#%a. P)#$"t(#$a# s)l 'ara*)ra '"$(#aka# (#t(k *)#)#t(ka#a-aka ka'ar s)l 'ara *)ra r)#'a9a#)*"a: ata( t"#$$" 9-l"s"t)*"a:.

• Pa'a -)r"t(#$a# s)l 'ara *)ra, aka#'"#"la" /(*la 'a# (k(ra# 'ar" s)l 'ara*)ra. B)#t(k s)l 'ara *)ra -(# aka#'")al(as" '" ba>a *"krsk-. S)$ala

"#?r*as" *(la" 'ar" /(*la, (k(ra# 'a#b)#t(k 'ar" s)l 'ara *)ra aka# b)r$(#a'ala* *)#'"a$#sa s(at( a#)*"a. 6($a-a'a -)*)r"ksaa# "#" 'a-at '"k)ta(" /)#"sa#)*"a b)r"k(t k)*(#$k"#a# -)#%)bab#%a.


13/51

• N"la" )*atkr"t *)r(-aka# ara %a#$ -al"#$s)r"#$ '"$(#aka# (#t(k *)#)#t(ka# a-aka

/(*la s)l 'ara *)ra t)rlal( t"#$$", t)rlal(

r)#'a ata( #r*al. H)*atkr"t s)/at"#%a*)r(-aka# (k(ra# %a#$ *)#)#t(ka# s)b)ra-aba#%ak /(*la s)l 'ara *)ra 'ala* sat(*"l"l"t)r 'ara ata( ')#$a# kata la"#-)rba#'"#$a# a#tara s)l 'ara *)ra ')#$a#k*-#)# 'ara %a#$ la"#.

• H)*atkr"t 'a-at '""t(#$ ')#$a# *)#$a*b"lsa*-)l 'ara -a'a /ar" ta#$a# ata( '"a*b"lla#$s(#$ -a'a )#a %a#$ t)rl)tak -a'a l)#$a#.

• S)l 'ara *)ra %a#$ t)r'a-at 'ala* sa*-)l

k)*('"a# '")#'a-ka# ')#$a# ara*)*(tar#%a *)#$$(#aka# alat s)#tr"?($al.E#'a-a# "#" k)*('"a# '" -r)s)#tas)ka# ')#$a#

/(*la k)s)l(r(a# 'ar" 'ara %a#$ t)r'a-at'ala* tab(#$, #"la" "#"la %a#$ '"#a*aka# #"la")*atkr"t.


14/51

• H)*$lb"# a'ala -"$*)# %a#$*)*b(at s)l 'ara b)r>ar#a *)ra%a#$ -a'a ak"r#%a aka# *)*b(at'ara *a#(s"a b)r>ar#a *)ra.M)#(r(t ?(#$s"#%a, )*$lb"#*)r(-aka# *)'"a tra#s-rt ks"$)# 'ar"-ar( -ar( k) /ar"#$a# t(b(. S)-)rt" k"tak)ta(" b)rsa*a, ks"$)# *)r(-aka#ba$"a# t)r-)#t"#$ 'ar" *)tabl"s*)t(b( (#t(k *)#$as"lka# )#)r$".H)*$lb"# /($a b)r?(#$s" *)*ba>akarb#'"ks"'a as"l *)tabl"s*) 'ar"

/ar"#$a# t(b( k) -ar( -ar( (#t(ks)la#/(t#%a '"k)l(arka# saat b)r#a?as.


15/51

• @ra#$ ')#$a# ka'ar )*$lb"#%a#$ r)#'a '"s)b(t ')#$a# "st"la

a#)*"a. Saat ka'ar )*$lb"#r)#'a *aka /(*la s)l 'ara *)ra-(# aka# r)#'a. 3)*"k"a# -(la

al#%a ')#$a# #"la" )*atkr"t.


16/51

• Tra#s-rtas" ks"$)# aka# t)r$a#$$('a# /ar"#$a# t(b( ra#$ %a#$ a#)*"a

aka# *)#$ala*" k)k(ra#$a# ks"$)#$(#a *)#$as"lka# )#)r$".

• @ra#$ %a#$ *)#$ala*" a#)*"a aka#*)rasa )-at l)la, l)*as, -(at,

$)l"sa 'a# t)rka'a#$ s)sak.• +)k(ra#$a# at b)s"

• P)r)*-(a# aka# l)b" *('a

*)#')r"ta a#)*"a b"la '"ba#'"#$ka#')#$a# lak" lak" kar)#a -)r)*-(a#*)#$ala*" k)"la#$a# 'ara t"a- b(la#saat *)#str(as". P)r)*-(a# /($a

r)#ta# *)#$ala*" k)k(ra#$a# at b)s".


17/51

• P)r'araa#• P)r'araa# %a#$ ba#%ak saat tra(*a ba"k '"

'ala* *a(-(# '" l(ar t(b( aka# *)#%)babka#

a#)*"a 'ala* >akt( %a#$ r)lat"? s"#$kat.P)r'araa# 'ala* /(*la ba#%ak b"asa#%at)r/a'" -a'a *aa$ kr#"s %a#$ *)#%)babka#-)rl(kaa# -a'a '"#'"#$ la*b(#$.

• )#)t"k

• +)la"#a# )r)'"t)r ata( k)t(r(#a# /($a b"sa*)#%)babka# a#)*"a. +)la"#a# $)#)t"k "#"t)r(ta*a t)r/a'" -a'a (*(r s)l 'ara *)ra%a#$ t)rla*-a( -)#')k s)"#$$a s)l 'ara*)ra %a#$ b)r)'ar 'ala* t(b( aka# s)lal(

k)k(ra#$a#. A#)*"a /)#"s "#" '"k)#al ')#$a##a*a sickle cell anemia. a#$$(a# $)#)t"k /($ab"sa *)#"*-a )*$lb"# %a#$ *a#a -r'(ks")*$lb"# *)#/a'" sa#$at r)#'a. +)la"#a# "#"k"ta k)#al ')#$a# #a*a talas)*"a.


18/51

• +)k(ra#$a# "ta*"# B12• A#)*"a %a#$ '"ak"batka# l) kar)#a

k)k(ra#$a# "ta*"# B12 '"k)#al ')#$a##a*a a#)*"a -)r#"s"sa.• +)k(ra#$a# asa* ?lat• +)k(ra#$a# asa* ?lat /($a s)r"#$

*)#%)babka# a#)*"a t)r(ta*a -a'a"b( "b( %a#$ s)'a#$ a*"l.• P)a#%a '"#'"#$ s)l 'ara *)ra• A#)*"a %a#$ '"s)babka# l) kar)#a

-)a#%a '"#'"#$ s)l 'ara *)ra'"k)#al ')#$a# #a*a a#)*"a )*l"t"k.&)aks" a#t"$)# a#t"b'" '"(r"$a" s)ba$a"b"a#$ k)rk t)r/a'"#%a a#)*"a /)#"s "#".


19/51

• a#$$(a# s(*s(* t(la#$

• S(*s(* t(la#$ s)ba$a" -abr"k

-r'(ks" s)l 'ara /($a b"sa*)#$ala*" $a#$$(a# s)"#$$a t"'akb"sa b)r?(#$s" ')#$a# ba"k 'ala*

*)#$as"lka# s)l 'ara *)ra %a#$b)rk(al"tas. a#$$(a# -a'a s(*s(*t(la#$ b"asa#%a '"s)babka# l)

kar)#a *)statas) s)l ka#k)r 'ar"t)*-at la"#.


20/51

• S)-)rt" al#%a -)#%ak"t la"#, -)#$bata#a#)*"a /($a ar(s '"t(/(ka# -a'a -)#%)babt)r/a'"#%a a#)*"a. M"sal#%a a#)*"a %a#$

'"s)babka# l) -)r'araa# -a'a (s(s*aka -)r'araa# "t( ar(s k"ta )#t"ka#(#t(k *)#)$a b)rla#/(t#%a a#)*"a. 6"ka*)*a#$ '"-)rl(ka#, -)ras" 'a-at '"lak(ka#

-a'a k)a'aa# t)rt)#t(.• S(-l)*)# b)s" '"-)rl(ka# -a'a a#)*"a %a#$

'"s)babka# l) kar)#a k)k(ra#$a# at b)s".P)*b)r"a# s(#t"ka# "ta*"# B12 '"-)rl(ka#

(#t(k *)#$kr)ks" a#)*"a -)r#"s"sa. Tra#s?(s" 'ara *)r(-aka# -"l"a# (#t(ka#)*"a %a#$ '"s)babka# l) -)r'araa#)bat.


21/51

BAB III. +E&AN+A +@NSEP

• Alasa# sa%a *)*"l" kas(s BBL&a'ala

– T"#$$"#%a BBL& '" P(sk)s*as+)a*ata# +(*ba#$a# s)la*ata(#2010

– Ba#%ak#%a "b( a*"l %a#$ *)*-(#%a"ka'ar Hb 11 *$ 'L


22/51

KERANGKA KONSEP

BBL&Hb ibu hamil

< mg!dL


23/51

HIPOTESIS

• Hipotesis nul (Ho)

Tidak ada hubungan yang

bermakna antara kadar Hb

ibu hamil dengan BBLR

• Hipotesis alternati (Ha)

!da hubungan yang

bermakna antara kadar Hb

ibu hamil dengan BBLR


24/51

"#$R%&'"(%L )%R'%B$L

– M)*b)r"ka# (ra"a# s-)s"


25/51

– Var"ab)l "#')-)#')#t "b( a*"l

')#$a# ka'ar Hb 11 *$'l 'a# ka'arHb %a#$ #r*al.

– ar"ab)l ')-)#')#t BBL& B)ratba'a# (k(-

B)r'asarka# jenis, k) '(a ar"ab)lt)rs)b(t

t)r*as(k skala #*"#al

B)rart" b)r'asarka# sifat, k) '(a ar"ab)lt)rs)b(t

t)r*as(k kat)$r"k


26/51

1.Variabel yg diteliti ! ba%" %a#$

*)#$ala*" BBL&

2.Denisi ! Ba%" %a#$ la"r ')#$a#b)rat %a#$ r)#'a ata( (k(- -a'a

"b( 8 "b( a*"l %a#$ *)*-(#%a"ka'ar Hb 11 *$ 'L

!."ara #$#r ! 'ata ANC 'ata

k)la"ra# '" P(sk)s*as s)la*a ta(#2010.


27/51

%.Alat #$#r ! k("s"#)r&.'asil #$#r !

– 50 BBL& FFFFF D Ib( ka'ar Hb 11*$'l

– 55 ba%" ')#$a# b)rat (k(- FFFF 0 Ib( ka'ar Hb 11 *$'l

(.S$ala #$#r ! kat)$r"k, #*"#al


28/51

BAB IV. MET@3@L@IPENELITIAN

. *esain penelitian

+. Tempat dan ,aktu penelitian

-. #pulasi dan sampel

/. Teknik pengambilan sampel

0. 1riteria inklusi dan eksklusi

2. #engumpulan data

3. %lat ukur

4. #englahan data


29/51

P@PULA

SI

+A3A& Hb

11*$'lDr$

+A3A& TI3A+ Hb 11*$'l14 r$

+A3A& Hb 11*$'l0r$ BE&AT

CU+UP 55BAGI

+A3A& TI3A+ Hb 11*$'l25 r$

BBL&50 BAGI


30/51

2. M)#$(*-(lka# sa*-)l %$ aka#'"t)l"t"

– A'a 2 t)k#"k -)#$(*-(la# sa*-)l!1. &a#'*

• S"*-l)

• Strat"s


31/51

P)#$(*-(la# 'ata

• Taa- -)rs"a-a# – M)#)#t(ka# 'a# *)r(*(ska# t(/(a#

-)#)l"t"a#

–M)#)#t(ka# *)t') %$ '"$(#aka# – M)#)#t(ka# t)k#"k -)#$(*-(la# 'ata

– M)#%(s(# -)'*a# 'a?tar -)rta#%aa# %$'-t *)#'a-at t(/(a#

– M)#)#t(ka# sasara# – M)#)#t(ka# t)*-at 'ata '"k(*-(lka# /*lr)s-#')#

– S"a-a -)laksa#a -)#$(*-(la# 'ata


32/51

• Taa- -)laksa#aa# ! – P)#$(*-(la# 'ata

– S(-)r"s" la-a#$a#• S(*b)r 'ata !

– 3a-at 'ar" r)ka* *)'"k

– Ba'a# "#sta#s" r)s*" k)s)ata# ) !BPS

– Mas%arakat-)#')r"ta %$ b)rbat

–P)t($as &S


33/51

T)k#"k P)#$(*-(la# 'ata

1. a>a#ara

2. A#$k)t

. P)#$a*ata#4. P)*)r"ksaa#


34/51

>a>a#ara

• I#t)raks" k*(#"kas" la#$s(#$• U#t(k M)*-)rl) 'ata %$ b)rs"?at ?akta.• M)#$)ta(" s"ka-, -)#'a-at, -)#$ala*a#,

'll.• +)(#t(#$a# ! – l)ks"b)l, /a>aba# '"-)rl) s)$)ra, 'a-at

*)#"la" k)b)#ara#, *)*ba#t( r)s-#')#*)#$"#$at al2 %$ l(-a

• +)r($"a# – B(t( t)#a$a, >akt(, b"a%a %$ b)sar – M)l)laka# b"la -)rta#%aa# t)rlal( ba#%ak, 'll.


35/51

A#$k)t

• P)ta#%aa# t)rt(l"s

• 3a-at '"lak(ka# *)lal(" -s

• +)(t(#$a# ! – M(ra, tak b(t( b#%k t)#a$a, '-t '" (la#$• +)r($"a# !• 6a>aba# t"'ak s-#ta#• Ba#%ak t)r/a'" ##Fr)s-#

• A'a %$ $a '" />b• P)#$"r"*a# s)r"#$ t)rla*bat• S)r"#$ tak '" "s".


36/51

P)#$a*ata#

• U#t(k )*b(kt"ka# k)b)#ara# /a>aba# r)s-#')#

• 3"$(#aka# (#t(k *)#$(ra#$" al2%$ tak -)rl( '" ta#%aka#.


37/51

-)*)r"ksaa#

• M)lal(" -)*)r"ksaa# labrat(r"(*,


38/51

4. +r"t)r"a "#kl(s" 'a# )kskl(s" – P)#'('(k %$ aka# '"a*b"l sb$ sa*-)l

ar(s b)rasal 'ar" k)a*ata# "-(kat – T"'ak bl) 'ar" k)a*ata# la"# b"as


39/51

5. P)#$(*-(la# 'a# -)#$laa# 'ata – P)#$laa# 'ata a'a 5 la#$ka!

1. E'"t"#$2. Cat"#$

. Pr)ss"#$

4. Cl)a#"#$5. U/" stat"st"k


40/51


41/51

BAB V. HASIL PENELITIAN

• U/" stat"st"k 8

*)*b(kt"ka# a'a#%a (b(#$a# %$

b)r*ak#a a#tara ar"ab)l s)bab 'a#ak"bat.


42/51

Hasil penelitian

BBLR BE&AT CU+UP 6(*la+A3A& Hb

11 *$ 'l

D a 0 b DD aJb

+A3A& TI3A+

Hb11 *$'l

14 25 ' K J'

6(*la 50aJ

55bJ'

105aJbJJ'


43/51

))*R )ERA+ ",K,P +-tal

+A3A& Hb11*$ 'l

D955: 0945: DD

+A3A& TI3A+ Hb11 *$ 'l

14 9D: 259D4: K

Ttal 50 55 105

U6I ALPHA BETA E&&@&


44/51

# # 9ZO 2PQ J ZR PQ JP Q2:

9P F P:

56 : 782

59 : 74/+

# : ; # = #+ ># : utk alpha beta errr #?c!c=d ? +!3?7-2

utk uji sampel # ? 70

#+ : +@ #

A : #>A : #

A+ : #+


45/51

• Al-a )rrr

3"k! P10,D

P2 120 . 0,D 0,42

P 90,D J 0,42: 0,KD

Q 1 8 0,KD0,D04Q1 1 8 0,D 0,D4

Q2 1 8 0,42 0,5D


46/51

# # 9ZO 2PQ J ZR PQ J PQ2:

9P F P:

1052 52,5 9ZO 2. 0,KD. 0,D04 J 0,40,D. 0,D4 J0,42. 0,5D:

90,DF 0,42:

ZO 0,17D-a'a tab)l -rbab"l"t%

O 1 8 . 100 '"kal" 2

6a'" O )rrr %


47/51

• B)ta )rrr

3"k! P10,D

P2 120 . 0,D 0,42

P 90,D J 0,42: 0,KD

Q 1 8 0,1K0,1Q1 1 8 0,17 0,

Q2 1 8 0,2 0,


48/51

# # 9ZO 2PQ J ZR PQ J PQ2:

9P F P:

1052 52,5 9ZO 2. 0,KD. 0,D04 J 0,40,D. 0,D4J 0,42. 0,5D:

90,DF 0,42:

ZO 0,17D-a'a tab)l -rbab"l"t%

O 1 8 0, 100 t"'ak '"kal" 2

6a'" R )rrr %


49/51

BAB VI. PEMBAHASAN

BAB VII +ESIMPULAN


50/51

BAB VII. +ESIMPULAN SA&AN


51/51

3ATA& PUSTA+A